Advancement and prospects of bioinformatics analysis for studying bioactive peptides from food-derived protein: Sequence, structure, and functions

TrAC - Trends in Analytical Chemistry

Volumn 105, Issue , 2018, Pages 7-17

  Tu, Maolin ^a,b   Cheng, Shuzhen ^a,c   Lu, Weihong ^b   Du, Ming ^a,b  

^a DALIAN POLYTECHNIC UNIVERSITY   (China)

^b HARBIN INSTITUTE OF TECHNOLOGY   (China)

^c CHINA AGRICULTURAL UNIVERSITY   (China)

Author keywords

Bioactive peptides; Bioinformatics; Food derived proteins; In silico prediction; Structural characteristics

Indexed keywords

BIOINFORMATICS;

BIOACTIVE PEPTIDES; BIOINFORMATICS ANALYSIS; BIOINFORMATICS METHODS; CHRONIC DISEASE; CONVENTIONAL METHODS; IN-SILICO; LOW TOXICITY; STRUCTURAL CHARACTERISTICS;

PEPTIDES;

ANTIAMNESTIC PEPTIDE; ANTIBIOTIC AGENT; ANTICOAGULANT AGENT; ANTIFUNGAL AGENT; ANTIHYPERTENSIVE AGENT; ANTIINFECTIVE AGENT; ANTIINFLAMMATORY AGENT; ANTINEOPLASTIC ALKALOID; ANTIOXIDANT; ANTIVIRUS AGENT; BIOACTIVE PEPTIDE; CELIAC TOXIC PEPTIDE; CENTRAL STIMULANT AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIPEPTIDYL PEPTIDASE IV INHIBITOR; ERYTHROMYCIN INHIBITOR PEPTIDE; GUANINE NUCLEOTIDE EXCHANGE FACTOR; HEMOLYTIC AGENT; HEPARIN BINDING PROTEIN; IMMUNOMODULATING AGENT; IMMUNOSTIMULATING AGENT; NATRIURETIC FACTOR; NEUROPEPTIDE; OPIATE AGONIST; OPIATE PEPTIDE; PEPTIDE DERIVATIVE; POLYPEPTIDE ANTIBIOTIC AGENT; PROTEIN KINASE C INHIBITOR; UNCLASSIFIED DRUG; UNINDEXED DRUG; UROTENSIN RECEPTOR ANTAGONIST;

AMINO ACID SEQUENCE; BIOINFORMATICS; BIOLOGICAL ACTIVITY; COMPUTER MODEL; FUNCTIONAL FOOD; HUMAN; HYDROLYSIS; MOLECULAR DOCKING; MOLECULAR MECHANICS; PHYSICAL CHEMISTRY; PREDICTIVE VALIDITY; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN FUNCTION; PROTEIN INTAKE; PROTEIN MODIFICATION; PROTEIN STRUCTURE; REGULATORY MECHANISM; REVIEW; SOLUBILITY; WORKFLOW;

EID: 85046828932     PISSN: 01659936     EISSN: 18793142     Source Type: Journal    
DOI: 10.1016/j.trac.2018.04.005     Document Type: Review

References (100)

1. Manikkam, V., Vasiljevic, T., Donkor, O.N., Mathai, M.L., A review of potential marine-derived hypotensive and anti-obesity peptides. Crit. Rev. Food Sci. Nutr. 56 (2016), 92–112.
2. Martínezaugustin, O., Riverogutiérrez, B., Mascaraque, C., Sánchez, d.M.F., Food derived bioactive peptides and intestinal barrier function. Int. J. Mol. Sci. 15 (2014), 22857–22873.
3. Udenigwe, C.C., Aluko, R.E., Food protein-derived bioactive peptides: production, processing, and potential health benefits. J. Food Sci. 77 (2012), R11–R24.
4. Li-Chan, E.C., Bioactive peptides and protein hydrolysates: research trends and challenges for application as nutraceuticals and functional food ingredients. Curr. Opin. Food Sci. 1 (2015), 28–37.
5. Valdés, A., Cifuentes, A., León, C., Foodomics evaluation of bioactive compounds in foods. Trends Anal. Chem. 96 (2017), 2–13.
6. Agyei, D., Ongkudon, C.M., Wei, C.Y., Chan, A.S., Danquah, M.K., Bioprocess challenges to the isolation and purification of bioactive peptides. Food Bioprod. Process. 98 (2016), 244–256.
7. Ji, C., Jing, H., Zhang, J., Jing, H., Fu, Y., Hang, Q., Yue, S., Yu, C., Omics-prediction of bioactive peptides from the edible cyanobacterium Arthrospira platensis proteome. J. Sci. Food Agric. 98 (2017), 984–990.
8. Minkiewicz, P., Dziuba, J., Iwaniak, A., Dziuba, M., Darewicz, M., BIOPEP database and other programs for processing bioactive peptide sequences. J. AOAC Int. 91 (2008), 965–980.
9. Tu, M., Feng, L., Wang, Z., Qiao, M., Shahidi, F., Lu, W., Du, M., Sequence analysis and molecular docking of antithrombotic peptides from casein hydrolysate by trypsin digestion. J. Funct. Foods 32 (2017), 313–323.
10. Lin, K., Zhang, L.W., Han, X., Cheng, D.Y., Novel angiotensin I-converting enzyme inhibitory peptides from protease hydrolysates of Qula casein: quantitative structure-activity relationship modeling and molecular docking study. J. Funct. Foods 32 (2017), 266–277.
11. Mooney, C., Haslam, N.J., Pollastri, G., Shields, D.C., Towards the improved discovery and design of functional peptides: common features of diverse classes permit generalized prediction of bioactivity. PLoS One, 7, 2012, e45012.
12. Nongonierma, A., Fitzgerald, D., Learnings from quantitative structure activity relationship (QSAR) studies with respect to food protein-derived bioactive peptides: a review. RSC Adv. 6 (2016), 75400–75413.
13. Sun, H., Chang, Q., Liu, L., Chai, K., Lin, G., Huo, Q., Zhao, Z., Zhao, Z., High-throughput and rapid screening of novel ACE inhibitory peptides from sericin source and inhibition mechanism by using in silico and in vitro prescriptions. J. Agric. Food Chem., 2017, 10020–10028.
14. Vijayakumar, V., Guerrero, A.N., Davey, N., Lebrilla, C.B., Shields, D.C., Khaldi, N., EnzymePredictor: a tool for predicting and visualizing enzymatic cleavages of digested proteins. J. Proteome Res. 11 (2012), 6056–6065.
15. Dupont, D., Peptidomic as a tool for assessing protein digestion. Curr. Opin. Food Sci. 16 (2017), 53–58.
16. Ibáñez, C., Simó, C., Garcíacañas, V., Cifuentes, A., Castropuyana, M., Metabolomics, peptidomics and proteomics applications of capillary electrophoresis-mass spectrometry in Foodomics: a review. Anal. Chim. Acta 802 (2013), 1–13.
17. Mooney, C., Haslam, N.J., Holton, T.A., Pollastri, G., Shields, D.C., PeptideLocator: prediction of bioactive peptides in protein sequences. Bioinformatics 29 (2013), 1120–1126.
18. Yu, F., Young, J.F., Løkke, M.M., Lametsch, R., Aluko, R.E., Therkildsen, M., Revalorisation of bovine collagen as a potential precursor of angiotensin I-converting enzyme (ACE) inhibitory peptides based on in silico and in vitro protein digestions. J. Funct. Foods 24 (2016), 196–206.
19. Fu, Y., Wu, W., Zhu, M., Xiao, Z., In silico assessment of the potential of patatin as a precursor of bioactive peptides. J. Food Biochem. 40 (2016), 366–370.
20. Udenigwe, C.C., Towards rice bran protein utilization: in silico insight on the role of oryzacystatins in biologically-active peptide production. Food Chem. 191 (2016), 135–138.
21. Mine, Y., Shahidi, F., Mine, Y., Shahidi, F., Nutraceutical Proteins and Peptides in Health and Disease, vol. 56, 2005, CRC Press, 96–108.
22. Pan, D., Cao, J., Guo, H., Zhao, B., Studies on purification and the molecular mechanism of a novel ACE inhibitory peptide from whey protein hydrolysate. Food Chem. 130 (2012), 121–126.
23. Jia, J., Wu, Q., Yan, H., Gui, Z., Purification and molecular docking study of a novel angiotensin-I converting enzyme (ACE) inhibitory peptide from alcalase hydrolysate of ultrasonic-pretreated silkworm pupa (Bombyx mori) protein. Process Biochem. 50 (2015), 876–883.
24. Wang, X., Chen, H., Fu, X., Li, S., Wei, J., A novel antioxidant and ACE inhibitory peptide from rice bran protein: biochemical characterization and molecular docking study. LWT – Food Sci. Technol. 75 (2017), 93–99.
25. Ndiaye, F., Vuong, T., Duarte, J., Aluko, R.E., Matar, C., Anti-oxidant, anti-inflammatory and immunomodulating properties of an enzymatic protein hydrolysate from yellow field pea seeds. Eur. J. Nutr. 51 (2012), 29–37.
26. Rani, S., Pooja, K., Pal, G.K., Exploration of potential angiotensin converting enzyme inhibitory peptides generated from enzymatic hydrolysis of goat milk proteins. Biocatal. Agric. Biotechnol. 11 (2017), 83–88.
27. Hsieh, C.H., Wang, T.Y., Hung, C.C., Jao, C.L., Hsieh, Y.L., Wu, S.X., Hsu, K.C., In silico, in vitro and in vivo analyses of dipeptidyl peptidase IV inhibitory activity and the antidiabetic effect of sodium caseinate hydrolysate. Food Funct. 7 (2016), 1122–1128.
28. Lafarga, T., O'Connor, P., Hayes, M., Identification of novel dipeptidyl peptidase-IV and angiotensin-I-converting enzyme inhibitory peptides from meat proteins using in silico analysis. Peptides 59 (2014), 53–62.
29. Dziuba, B., Dziuba, M., New milk protein-derived peptides with potential antimicrobial activity: an approach based on bioinformatic studies. Int. J. Mol. Sci. 15 (2014), 14531–14545.
30. Tulipano, G., Faggi, L., Nardone, A., Cocchi, D., Caroli, A.M., Characterisation of the potential of β-lactoglobulin and α-lactalbumin as sources of bioactive peptides affecting incretin function: in silico and in vitro comparative studies. Int. Dairy J. 48 (2015), 66–72.
31. Agyei, D., Tambimuttu, S., Kasargod, B., Gao, Y., He, L., Quick and low cost immobilization of proteinases on polyesters: comparison of lactobacilli cell-envelope proteinase and trypsin for protein degradation. J. Biotechnol. 188 (2014), 53–60.
32. Pokora, M., Eckert, E., Zambrowicz, A., Bobak, Ł., Szołtysik, M., Dąbrowska, A., Chrzanowska, J., Polanowski, A., Trziszka, T., Biological and functional properties of proteolytic enzyme-modified egg protein by-products. Food Sci. Nutr. 1 (2013), 184–195.
33. Klompong, V., Benjakul, S., Kantachote, D., Shahidi, F., Antioxidative activity and functional properties of protein hydrolysate of yellow stripe trevally (Selaroides leptolepis) as influenced by the degree of hydrolysis and enzyme type. Food Chem. 102 (2007), 1317–1327.
34. Rodriguez Patino, J.M., Miñones, C.J., Millán, L.H., Pedroche Jiménez, J.J., Carrera, S.C., Pizones, V., Millán, R.F., Interfacial and foaming properties of enzyme-induced hydrolysis of sunflower protein isolate. Food Hydrocoll. 21 (2007), 782–793.
35. Wu, J.H., Wang, Z., Xu, S.Y., Enzymatic production of bioactive peptides from sericin recovered from silk industry wastewater. Process Biochem. 43 (2008), 480–487.
36. Majumder, K., Wu, J., A new approach for identification of novel antihypertensive peptides from egg proteins by QSAR and bioinformatics. Food Res. Int. 43 (2010), 1371–1378.
37. Yu, Z., Chen, Y., Zhao, W., Li, J., Liu, J., Chen, F., Identification and molecular docking study of novel angiotensin-converting enzyme inhibitory peptides from salmo salar using in silico methods. J. Sci. Food Agric., 2018, 10.1002/jsfa.8908.
38. Gu, Y., Majumder, K., Wu, J., QSAR-aided in silico approach in evaluation of food proteins as precursors of ACE inhibitory peptides. Food Res. Int. 44 (2011), 2465–2474.
39. Nongonierma, A.B., Fitzgerald, R.J., Strategies for the discovery and identification of food protein-derived biologically active peptides. Trends Food Sci. Technol. 69 (2017), 289–305.
40. Butré, C.I., Sforza, S., Wierenga, P.A., Gruppen, H., Determination of the influence of the pH of hydrolysis on enzyme selectivity of Bacillus licheniformis protease against whey protein isolate. Int. Dairy J. 44 (2014), 44–53.
41. Inouye, K., Nakano, K., Asaoka, K., Yasukawa, K., Effects of thermal treatment on the coagulation of soy proteins induced by subtilisin Carlsberg. J. Agric. Food Chem. 57 (2009), 717–723.
42. Ruiz Ruiz, J.C., Betancur Ancona, D.A., Segura Campos, M.R., Bioactive vegetable proteins and peptides in lipid-lowering; nutraceutical potential. Nutr. Hosp. 29 (2014), 776–784.
43. Agyei, D., Pan, S., Acquah, C., Bekhit, E.D.A., Danquah, M.K., Structure-informed detection and quantification of peptides in food and biological fluids. J. Food Biochem., 6, 2017.
44. Jollès, P., Lévytoledano, S., Fiat, A.M., Soria, C., Gillessen, D., Thomaidis, A., Dunn, F.W., Caen, J.P., Analogy between fibrinogen and casein. Effect of an undecapeptide isolated from kappa-casein on platelet function. Eur. J. Biochem. 158 (1986), 379–382.
45. Korhonen, H., Pihlanto, A., Bioactive peptides: production and functionality. Int. Dairy J. 16 (2006), 945–960.
46. Hancock, R.E., Sahl, H.-G., Antimicrobial and host-defense peptides as new anti-infective therapeutic strategies. Nat. Biotechnol. 24 (2006), 1551–1557.
47. Nongonierma, A.B., Mazzocchi, C., Paolella, S., Fitzgerald, R.J., Release of dipeptidyl peptidase IV (DPP-IV) inhibitory peptides from milk protein isolate (MPI) during enzymatic hydrolysis. Food Res. Int. 94 (2017), 79–89.
48. Thomas, A., Deshayes, S., Decaffmeyer, M., Eyck, M.H.V., Charloteaux, B., Brasseur, R., Prediction of peptide structure: how far are we?. Proteins Struct. Funct. Bioinform. 65 (2006), 889–897.
49. Beaufays, J., Lins, L., Thomas, A., Brasseur, R., In silico predictions of 3D structures of linear and cyclic peptides with natural and non-proteinogenic residues. J. Pept. Sci. 18 (2012), 17–24.
50. Zhang, J., He, Z., Wang, Q., Barz, B., Kosztin, I., Yi, S., Xu, D., Prediction of protein tertiary structures using MUFOLD. Methods Mol. Biol. 815 (2012), 3–13.
51. Shen, Y., Maupetit, J., Derreumaux, P., Tufféry, P., Improved PEP-FOLD approach for peptide and miniprotein structure prediction. J. Chem. Theor. Comput. 10 (2014), 4745–4758.
52. Singh, S., Singh, H., Tuknait, A., Chaudhary, K., Singh, B., Kumaran, S., Raghava, G.P.S., PEPstrMOD: structure prediction of peptides containing natural, non-natural and modified residues. Biol. Direct, 10, 2015, 73.
53. Hung, L.H., Ngan, S.C., Liu, T., Samudrala, R., PROTINFO: new algorithms for enhanced protein structure predictions. Nucleic Acids Res. 33 (2005), 77–80.
54. Bystroff, C., Yu, S., Fully automated ab initio protein structure prediction using I-SITES, HMMSTR and ROSETTA. Bioinformatics 18 (2002), S54–S61.
55. Roy, A., Kucukural, A., Zhang, Y., I-TASSER: a unified platform for automated protein structure and function prediction. Nat. Protoc. 5 (2010), 725–738.
56. Lópezmartínez, R., Ramírezsalinas, G.L., Correabasurto, J., Barrón, B.L., Inhibition of influenza A virus infection in vitro by peptides designed in silico. PLoS One, 8, 2013, e76876.
57. Ronald, M., Muthuoandi, J., Ekka, S.P., Madavan, J., Williams, S., Sequence analysis and peptide modeling studies on Aedes aegypti using insilico tools and database. Int. J. Novel Trends Pharmaceut. Sci. 5 (2015), 70–73.
58. Ponder, J.W., Case, D.A., Force fields for protein simulations. Adv. Protein Chem., 66, 2003, 27.
59. Guedes, I.A., Magalhães, C.S.D., Dardenne, L.E., Receptor-ligand molecular docking. Biophys. Rev. 6 (2014), 75–77.
60. Wu, Q., Jia, J., Yan, H., Du, J., Gui, Z., A novel angiotensin-І converting enzyme (ACE) inhibitory peptide from gastrointestinal protease hydrolysate of silkworm pupa (Bombyx mori) protein: biochemical characterization and molecular docking study. Peptides 68 (2015), 17–24.
61. Velarde-Salcedo, A.J., Barrera-Pacheco, A., Lara-González, S., Montero-Morán, G.M., Díaz-Gois, A., de Mejia, E.G., de la Rosa, A.P.B., In vitro inhibition of dipeptidyl peptidase IV by peptides derived from the hydrolysis of amaranth (Amaranthus hypochondriacus L.) proteins. Food Chem. 136 (2013), 758–764.
62. Jing, P., Qian, B., He, Y., Zhao, X., Zhang, J., Zhao, D., Lv, Y., Deng, Y., Screening milk-derived antihypertensive peptides using quantitative structure activity relationship (QSAR) modelling and invitro/invivo studies on their bioactivity. Int. Dairy J. 35 (2014), 95–101.
63. Qi, C., Lin, G., Rong, Z., Wu, W., Studies on the bioactivities of ACE-inhibitory peptides with phenylalanine C-terminus using 3D-QSAR, molecular docking and in vitro evaluation. Mol. Inform., 36, 2017, 1600157.
64. Kim, H.O., Li-Chan, E.C., Quantitative structure-activity relationship study of bitter peptides. J. Agric. Food Chem. 54 (2006), 10102–10111.
65. Maehashi, K., Huang, L., Bitter peptides and bitter taste receptors. Cell. Mol. Life Sci. CMLS 66 (2009), 1661–1671.
66. Pripp, A.H., Ardö, Y., Modelling relationship between angiotensin-(I)-converting enzyme inhibition and the bitter taste of peptides. Food Chem. 102 (2007), 880–888.
67. Wang, W., Mejia, E.G.D., A new frontier in soy bioactive peptides that may prevent age-related chronic diseases. Compr. Rev. Food Sci. Food Saf. 4 (2010), 63–78.
68. He, R., Aluko, R.E., Ju, X.R., Evaluating molecular mechanism of hypotensive peptides interactions with renin and angiotensin converting enzyme. PLoS One, 9, 2014, e91051.
69. Fu, Y., Alashi, A.M., Young, J.F., Therkildsen, M., Aluko, R.E., Enzyme inhibition kinetics and molecular interactions of patatin peptides with angiotensin I-converting enzyme and renin. Int. J. Biol. Macromol. 101 (2017), 207–213.
70. Ni, H., Li, L., Liu, G., Hu, S.Q., Inhibition mechanism and model of an angiotensin I-converting enzyme (ACE)-inhibitory hexapeptide from Yeast (Saccharomyces cerevisiae). PLoS One, 7, 2012, e37077.
71. Tu, Z., Volk, M., Shah, K., Clerkin, K., Liang, J.F., Constructing bioactive peptides with pH-dependent activities. Peptides 30 (2009), 1523–1528.
72. Xie, C.L., Choung, S.Y., Cao, G.P., Lee, K.W., Choi, Y.J., In silico investigation of action mechanism of four novel angiotensin-I converting enzyme inhibitory peptides modified with Trp. J. Funct. Foods 17 (2015), 632–639.
73. Wang, P., Li, Y., Shao, Q., Zhou, W., Wang, K., Targeting human secretory phospholipase A2 with designed peptide inhibitors for inflammatory therapy. J. Drug Target. 23 (2015), 140–146.
74. Wang, Y., Yang, Y.J., Chen, Y.N., Zhao, H.Y., Zhang, S., Computer-aided design, structural dynamics analysis, and in vitro susceptibility test of antibacterial peptides incorporating unnatural amino acids against microbial infections. Comput. Methods Progr. Biomed. 134 (2016), 215–223.
75. Fowler, S.B., Poon, S., Muff, R., Chiti, F., Dobson, C.M., Zurdo, J., Rational design of aggregation-resistant bioactive peptides: reengineering human calcitonin. Proc. Natl. Acad. Sci. U. S. A. 102 (2005), 10105–10110.
76. Knowles, T.P., Shu, W., Devlin, G.L., Meehan, S., Auer, S., Dobson, C.M., Welland, M.E., Kinetics and thermodynamics of amyloid formation from direct measurements of fluctuations in fibril mass. Proc. Natl. Acad. Sci. U. S. A. 104 (2007), 10016–10021.
77. Dobson, C.M., Protein aggregation and its consequences for human disease. Protein Pept. Lett. 13 (2006), 219–227.
78. Caflisch, A., Computational models for the prediction of polypeptide aggregation propensity. Curr. Opin. Chem. Biol. 10 (2006), 437–444.
79. Balakin, K.V., Savchuk, N.P., Tetko, I.V., In silico approaches to prediction of aqueous and DMSO solubility of drug-like compounds: trends, problems and solutions. Curr. Med. Chem. 13 (2006), 223–241.
80. Hewitt, M., Cronin, M.T., Enoch, S.J., Madden, J.C., Roberts, D.W., Dearden, J.C., In silico prediction of aqueous solubility: the solubility challenge. J. Chem. Inf. Model. 49 (2009), 2572–2587.
81. Duchowicz, P.R., Talevi, A., Brunoblanch, L.E., Castro, E.A., New QSPR study for the prediction of aqueous solubility of drug-like compounds. Bioorg. Med. Chem. 16 (2008), 7944–7955.
82. Xiao, J., Burn, A., Tolbert, T.J., Increasing solubility of proteins and peptides by site-specific modification with betaine. Bioconj. Chem. 19 (2008), 1113–1118.
83. Trevino, S.R., Scholtz, J.M., Pace, C.N., Measuring and increasing protein solubility. J. Pharmaceut. Sci. 97 (2008), 4155–4166.
84. Trevino, S.R., Scholtz, J.M., Pace, C.N., Amino acid contribution to protein solubility: Asp, Glu, and Ser contribute more favorably than the other hydrophilic amino acids in RNase Sa. J. Mol. Biol. 366 (2007), 449–460.
85. Tu, M., Wang, C., Chen, C., Zhang, R., Liu, H., Lu, W., Jiang, L., Du, M., Identification of a novel ACE-inhibitory peptide from casein and evaluation of the inhibitory mechanisms. Food Chem. 256 (2018), 98–104.
86. Pina, A.S., Roque, A.C., Studies on the molecular recognition between bioactive peptides and angiotensin-converting enzyme. J. Mol. Recogn. 22 (2009), 162–168.
87. Muhammad, S.A., Fatima, N., In silico analysis and molecular docking studies of potential angiotensin-converting enzyme inhibitor using quercetin glycosides. Pharmacogn. Mag. 11 (2015), S123–S126.
88. Nongonierma, A.B., Mooney, C., Shields, D.C., Fitzgerald, R.J., Inhibition of dipeptidyl peptidase IV and xanthine oxidase by amino acids and dipeptides. Food Chem. 141 (2013), 644–653.
89. Ayan, S., Dogan, Ö., Ivantcova, P.M., Datsuk, N.G., Shulga, D.A., Chupakhin, V.I., Zabolotnev, D.V., Kudryavtsev, K.V., Asymmetric synthesis and molecular docking study of enantiomerically pure pyrrolidine derivatives with potential antithrombin activity. ChemInform 24 (2013), 838–843.
90. Chen, H.F., Dong, M.H., Ren, Y.J., Wang, F., Design, synthesis, biological evaluation and molecular docking studies of dabigatran analogs as potential thrombin inhibitors. J. Iran. Chem. Soc. 13 (2016), 347–357.
91. Amin, K.M., Abdel Gawad, N.M., Abdel Rahman, D.E., El Ashry, M.K., New series of 6-substituted coumarin derivatives as effective factor Xa inhibitors: synthesis, in vivo antithrombotic evaluation and molecular docking. Bioorg. Chem. 52 (2013), 31–43.
92. Trstenjak, U., Ilaš, J., Kikelj, D., Low molecular weight dual inhibitors of factor Xa and fibrinogen binding to GPIIb/IIIa with highly overlapped pharmacophores. Eur. J. Med. Chem. 64 (2013), 302–313.
93. Lu, S.H., Wu, J.W., Liu, H.L., Zhao, J.H., Liu, K.T., Chuang, C.K., Lin, H.Y., Tsai, W.B., Ho, Y., The discovery of potential acetylcholinesterase inhibitors: a combination of pharmacophore modeling, virtual screening, and molecular docking studies. J. Biomed. Sci., 18, 2011, 8.
94. Zhan, Z.J., Qi, Y., Wang, Z.L., Shan, W.G., Indole alkaloids from Ervatamia hainanensis with potent acetylcholinesterase inhibition activities. Bioorg. Med. Chem. Lett 20 (2010), 6185–6187.
95. Vikas, J., Interaction model of steviol glycosides from Stevia rebaudiana (Bertoni) with sweet taste receptors: a computational approach. Phytochemistry 116 (2015), 12–20.
96. Cheng, K., Zheng, Q.Z., Qian, Y., Shi, L., Zhao, J., Zhu, H.L., Synthesis, antibacterial activities and molecular docking studies of peptide and Schiff bases as targeted antibiotics. Bioorg. Med. Chem. Lett. 17 (2009), 7861–7871.
97. Honmore, V.S., Kandhare, A.D., Kadam, P.P., Khedkar, V.M., Sarkar, D., Bodhankar, S.L., Zanwar, A.A., Rojatkar, S.R., Natu, A.D., Isolates of Alpinia officinarum Hance as COX-2 inhibitors: evidence from anti-inflammatory, antioxidant and molecular docking studies. Int. Immunopharmacol. 33 (2016), 8–17.
98. Bouazizterrachet, S., Toumimaouche, A., Maouche, B., Taïrikellou, S., Modeling the binding modes of stilbene analogs to cyclooxygenase-2: a molecular docking study. J. Mol. Model. 16 (2010), 1919–1929.
99. Krishna, P.S., Vani, K., Prasad, M.R., Samatha, B., Charya, M.A.S., Shetty, P.R., In-silico molecular docking analysis of prodigiosin and cycloprodigiosin as COX-2 inhibitors. SpringerPlus, 2, 2013, 172.
100. Peng, W., Li, Y., Shao, Q., Zhou, W., Wang, K., Targeting human secretory phospholipase A2 with designed peptide inhibitors for inflammatory therapy. J. Drug Target. 23 (2015), 140–146.